Distinct functional and pharmacological properties of triheteromeric GluN1/GluN2A/GluN2B NMDA receptors

Neuron

Volumn 81, Issue 5, 2014, Pages 1084-1096

  Hansen, Kasper B ^a,b   Ogden, Kevin K ^a   Yuan, Hongjie ^a   Traynelis, Stephen F ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MONTANA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE RECEPTOR 1; GLUTAMATE RECEPTOR 2; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROTEIN GLUN2A; PROTEIN GLUN2B; UNCLASSIFIED DRUG; GLUTAMIC ACID; IFENPRODIL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; RECOMBINANT PROTEIN; TCN 201; TRAXOPRODIL; ZINC ION;

ANIMAL CELL; ARTICLE; BASIC LEUCINE ZIPPER MOTIF; BINDING SITE; BRAIN CORTEX; BRAIN REGION; CARBOXY TERMINAL SEQUENCE; CELL SURFACE; CONTROLLED STUDY; EXTRACELLULAR FLUID; FOREBRAIN; GENE SEQUENCE; HIPPOCAMPUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; SIGNAL TRANSDUCTION; DRUG BINDING SITE; DRUG RECEPTOR BINDING; FEMALE; GLUN1 GENE; GLUN2A GENE; GLUN2B GENE; PROTEIN ANALYSIS; PROTEIN ENGINEERING; RECEPTOR BLOCKING;

ANIMALS; DIMERIZATION; EXCITATORY AMINO ACID ANTAGONISTS; GLUTAMIC ACID; HEK293 CELLS; HUMANS; OOCYTES; PATCH-CLAMP TECHNIQUES; PIPERIDINES; PROTEIN BINDING; RATS; RECEPTORS, N-METHYL-D-ASPARTATE; RECOMBINANT PROTEINS; SULFONAMIDES; TRACE ELEMENTS; XENOPUS LAEVIS; ZINC;

EID: 84895480210     PISSN: 08966273     EISSN: 10974199     Source Type: Journal    
DOI: 10.1016/j.neuron.2014.01.035     Document Type: Article

References (61)

1. Al-Hallaq R.A., Conrads T.P., Veenstra T.D., Wenthold R.J. NMDA di-heteromeric receptor populations and associated proteins in rat hippocampus. J. Neurosci. 2007, 27:8334-8343.
2. Anson L.C., Chen P.E., Wyllie D.J., Colquhoun D., Schoepfer R. Identification of amino acid residues of the NR2A subunit that control glutamate potency in recombinant NR1/NR2A NMDA receptors. J. Neurosci. 1998, 18:581-589.
3. Arai R., Wriggers W., Nishikawa Y., Nagamune T., Fujisawa T. Conformations of variably linked chimeric proteins evaluated by synchrotron X-ray small-angle scattering. Proteins 2004, 57:829-838.
4. Bard L., Groc L. Glutamate receptor dynamics and protein interaction: lessons from the NMDA receptor. Mol. Cell. Neurosci. 2011, 48:298-307.
5. Benveniste M., Mayer M.L. Kinetic analysis of antagonist action at N-methyl-D-aspartic acid receptors. Two binding sites each for glutamate and glycine. Biophys. J. 1991, 59:560-573.
6. Bettini E., Sava A., Griffante C., Carignani C., Buson A., Capelli A.M., Negri M., Andreetta F., Senar-Sancho S.A., Guiral L., Cardullo F. Identification and characterization of novel NMDA receptor antagonists selective for NR2A- over NR2B-containing receptors. J. Pharmacol. Exp. Ther. 2010, 335:636-644.
7. Bettler B., Kaupmann K., Mosbacher J., Gassmann M. Molecular structure and physiological functions of GABA(B) receptors. Physiol. Rev. 2004, 84:835-867.
8. Bhatt J.M., Prakash A., Suryavanshi P.S., Dravid S.M. Effect of ifenprodil on GluN1/GluN2B N-methyl-D-aspartate receptor gating. Mol. Pharmacol. 2013, 83:9-21.
9. Brickley S.G., Misra C., Mok M.H., Mishina M., Cull-Candy S.G. NR2B and NR2D subunits coassemble in cerebellar Golgi cells to form a distinct NMDA receptor subtype restricted to extrasynaptic sites. J. Neurosci. 2003, 23:4958-4966.
10. Brock C., Boudier L., Maurel D., Blahos J., Pin J.P. Assembly-dependent surface targeting of the heterodimeric GABAB receptor is controlled by COPI but not 14-3-3. Mol. Biol. Cell 2005, 16:5572-5578.
11. Burger P.B., Yuan H., Karakas E., Geballe M., Furukawa H., Liotta D.C., Snyder J.P., Traynelis S.F. Mapping the binding of GluN2B-selective N-methyl-D-aspartate receptor negative allosteric modulators. Mol. Pharmacol. 2012, 82:344-359.
12. Cathala L., Misra C., Cull-Candy S. Developmental profile of the changing properties of NMDA receptors at cerebellar mossy fiber-granule cell synapses. J. Neurosci. 2000, 20:5899-5905.
13. Chazot P.L., Stephenson F.A. Molecular dissection of native mammalian forebrain NMDA receptors containing the NR1 C2 exon: direct demonstration of NMDA receptors comprising NR1, NR2A, and NR2B subunits within the same complex. J. Neurochem. 1997, 69:2138-2144.
14. Chazot P.L., Coleman S.K., Cik M., Stephenson F.A. Molecular characterization of N-methyl-D-aspartate receptors expressed in mammalian cells yields evidence for the coexistence of three subunit types within a discrete receptor molecule. J. Biol. Chem. 1994, 269:24403-24409.
15. Choi Y.B., Lipton S.A. Identification and mechanism of action of two histidine residues underlying high-affinity Zn2+ inhibition of the NMDA receptor. Neuron 1999, 23:171-180.
16. Clements J.D., Westbrook G.L. Activation kinetics reveal the number of glutamate and glycine binding sites on the N-methyl-D-aspartate receptor. Neuron 1991, 7:605-613.
17. Erreger K., Traynelis S.F. Allosteric interaction between zinc and glutamate binding domains on NR2A causes desensitization of NMDA receptors. J. Physiol. 2005, 569:381-393.
18. Erreger K., Traynelis S.F. Zinc inhibition of rat NR1/NR2A N-methyl-D-aspartate receptors. J. Physiol. 2008, 586:763-778.
19. Erreger K., Geballe M.T., Kristensen A., Chen P.E., Hansen K.B., Lee C.J., Yuan H., Le P., Lyuboslavsky P.N., Micale N., et al. Subunit-specific agonist activity at NR2A-, NR2B-, NR2C-, and NR2D-containing N-methyl-D-aspartate glutamate receptors. Mol. Pharmacol. 2007, 72:907-920.
20. Flint A.C., Maisch U.S., Weishaupt J.H., Kriegstein A.R., Monyer H. NR2A subunit expression shortens NMDA receptor synaptic currents in developing neocortex. J. Neurosci. 1997, 17:2469-2476.
21. Gray J.A., Shi Y., Usui H., During M.J., Sakimura K., Nicoll R.A. Distinct modes of AMPA receptor suppression at developing synapses by GluN2A and GluN2B: single-cell NMDA receptor subunit deletion in vivo. Neuron 2011, 71:1085-1101.
22. Hansen K.B., Clausen R.P., Bjerrum E.J., Bechmann C., Greenwood J.R., Christensen C., Kristensen J.L., Egebjerg J., Bräuner-Osborne H. Tweaking agonist efficacy at N-methyl-D-aspartate receptors by site-directed mutagenesis. Mol. Pharmacol. 2005, 68:1510-1523.
23. Hansen K.B., Ogden K.K., Traynelis S.F. Subunit-selective allosteric inhibition of glycine binding to NMDA receptors. J. Neurosci. 2012, 32:6197-6208.
24. Hansen K.B., Tajima N., Risgaard R., Perszyk R.E., Jørgensen L., Vance K.M., Ogden K.K., Clausen R.P., Furukawa H., Traynelis S.F. Structural determinants of agonist efficacy at the glutamate binding site of N-methyl-D-aspartate receptors. Mol. Pharmacol. 2013, 84:114-127.
25. Hatton C.J., Paoletti P. Modulation of triheteromeric NMDA receptors by N-terminal domain ligands. Neuron 2005, 46:261-274.
26. Jones S., Gibb A.J. Functional NR2B- and NR2D-containing NMDA receptor channels in rat substantia nigra dopaminergic neurones. J. Physiol. 2005, 569:209-221.
27. Kammerer R.A., Frank S., Schulthess T., Landwehr R., Lustig A., Engel J. Heterodimerization of a functional GABAB receptor is mediated by parallel coiled-coil alpha-helices. Biochemistry 1999, 38:13263-13269.
28. Karakas E., Simorowski N., Furukawa H. Structure of the zinc-bound amino-terminal domain of the NMDA receptor NR2B subunit. EMBO J. 2009, 28:3910-3920.
29. Karakas E., Simorowski N., Furukawa H. Subunit arrangement and phenylethanolamine binding in GluN1/GluN2B NMDA receptors. Nature 2011, 475:249-253.
30. Kew J.N., Trube G., Kemp J.A. A novel mechanism of activity-dependent NMDA receptor antagonism describes the effect of ifenprodil in rat cultured cortical neurones. J. Physiol. 1996, 497:761-772.
31. Kew J.N., Richards J.G., Mutel V., Kemp J.A. Developmental changes in NMDA receptor glycine affinity and ifenprodil sensitivity reveal three distinct populations of NMDA receptors in individual rat cortical neurons. J. Neurosci. 1998, 18:1935-1943.
32. Kirson E.D., Yaari Y. Synaptic NMDA receptors in developing mouse hippocampal neurones: functional properties and sensitivity to ifenprodil. J. Physiol. 1996, 497:437-455.
33. Kniazeff J., Bessis A.S., Maurel D., Ansanay H., Prézeau L., Pin J.P. Closed state of both binding domains of homodimeric mGlu receptors is required for full activity. Nat. Struct. Mol. Biol. 2004, 11:706-713.
34. Laube B., Hirai H., Sturgess M., Betz H., Kuhse J. Molecular determinants of agonist discrimination by NMDA receptor subunits: analysis of the glutamate binding site on the NR2B subunit. Neuron 1997, 18:493-503.
35. Lester R.A., Clements J.D., Westbrook G.L., Jahr C.E. Channel kinetics determine the time course of NMDA receptor-mediated synaptic currents. Nature 1990, 346:565-567.
36. Low C.M., Zheng F., Lyuboslavsky P., Traynelis S.F. Molecular determinants of coordinated proton and zinc inhibition of N-methyl-D-aspartate NR1/NR2A receptors. Proc. Natl. Acad. Sci. USA 2000, 97:11062-11067.
37. Luo J., Wang Y., Yasuda R.P., Dunah A.W., Wolfe B.B. The majority of N-methyl-D-aspartate receptor complexes in adult rat cerebral cortex contain at least three different subunits (NR1/NR2A/NR2B). Mol. Pharmacol. 1997, 51:79-86.
38. Maki B.A., Aman T.K., Amico-Ruvio S.A., Kussius C.L., Popescu G.K. C-terminal domains of N-methyl-D-aspartic acid receptor modulate unitary channel conductance and gating. J. Biol. Chem. 2012, 287:36071-36080.
39. Margeta-Mitrovic M., Jan Y.N., Jan L.Y. A trafficking checkpoint controls GABA(B) receptor heterodimerization. Neuron 2000, 27:97-106.
40. Nozaki C., Vergnano A.M., Filliol D., Ouagazzal A.M., Le Goff A., Carvalho S., Reiss D., Gaveriaux-Ruff C., Neyton J., Paoletti P., Kieffer B.L. Zinc alleviates pain through high-affinity binding to the NMDA receptor NR2A subunit. Nat. Neurosci. 2011, 14:1017-1022.
41. Paoletti P., Ascher P., Neyton J. High-affinity zinc inhibition of NMDA NR1-NR2A receptors. J. Neurosci. 1997, 17:5711-5725.
42. Paoletti P., Perin-Dureau F., Fayyazuddin A., Le Goff A., Callebaut I., Neyton J. Molecular organization of a zinc binding n-terminal modulatory domain in a NMDA receptor subunit. Neuron 2000, 28:911-925.
43. Paoletti P., Bellone C., Zhou Q. NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease. Nat. Rev. Neurosci. 2013, 14:383-400.
44. Piña-Crespo J.C., Gibb A.J. Subtypes of NMDA receptors in new-born rat hippocampal granule cells. J. Physiol. 2002, 541:41-64.
45. Preskorn S.H., Baker B., Kolluri S., Menniti F.S., Krams M., Landen J.W. An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder. J. Clin. Psychopharmacol. 2008, 28:631-637.
46. Punnakkal P., Jendritza P., Köhr G. Influence of the intracellular GluN2 C-terminal domain on NMDA receptor function. Neuropharmacology 2012, 62:1985-1992.
47. Rachline J., Perin-Dureau F., Le Goff A., Neyton J., Paoletti P. The micromolar zinc-binding domain on the NMDA receptor subunit NR2B. J. Neurosci. 2005, 25:308-317.
48. Rauner C., Köhr G. Triheteromeric NR1/NR2A/NR2B receptors constitute the major N-methyl-D-aspartate receptor population in adult hippocampal synapses. J. Biol. Chem. 2011, 286:7558-7566.
49. Sanz-Clemente A., Nicoll R.A., Roche K.W. Diversity in NMDA receptor composition: many regulators, many consequences. Neuroscientist 2013, 19:62-75.
50. Sensi S.L., Paoletti P., Koh J.Y., Aizenman E., Bush A.I., Hershfinkel M. The neurophysiology and pathology of brain zinc. J. Neurosci. 2011, 31:16076-16085.
51. Sheng M., Cummings J., Roldan L.A., Jan Y.N., Jan L.Y. Changing subunit composition of heteromeric NMDA receptors during development of rat cortex. Nature 1994, 368:144-147.
52. Stocca G., Vicini S. Increased contribution of NR2A subunit to synaptic NMDA receptors in developing rat cortical neurons. J. Physiol. 1998, 507:13-24.
53. Tang T.T., Badger J.D., Roche P.A., Roche K.W. Novel approach to probe subunit-specific contributions to N-methyl-D-aspartate (NMDA) receptor trafficking reveals a dominant role for NR2B in receptor recycling. J. Biol. Chem. 2010, 285:20975-20981.
54. Tovar K.R., Westbrook G.L. The incorporation of NMDA receptors with a distinct subunit composition at nascent hippocampal synapses in vitro. J. Neurosci. 1999, 19:4180-4188.
55. Tovar K.R., Westbrook G.L. Amino-terminal ligands prolong NMDA Receptor-mediated EPSCs. J. Neurosci. 2012, 32:8065-8073.
56. Tovar K.R., McGinley M.J., Westbrook G.L. Triheteromeric NMDA receptors at hippocampal synapses. J. Neurosci. 2013, 33:9150-9160.
57. Traynelis S.F., Burgess M.F., Zheng F., Lyuboslavsky P., Powers J.L. Control of voltage-independent zinc inhibition of NMDA receptors by the NR1 subunit. J. Neurosci. 1998, 18:6163-6175.
58. Traynelis S.F., Wollmuth L.P., McBain C.J., Menniti F.S., Vance K.M., Ogden K.K., Hansen K.B., Yuan H., Myers S.J., Dingledine R. Glutamate receptor ion channels: structure, regulation, and function. Pharmacol. Rev. 2010, 62:405-496.
59. Vicini S., Wang J.F., Li J.H., Zhu W.J., Wang Y.H., Luo J.H., Wolfe B.B., Grayson D.R. Functional and pharmacological differences between recombinant N-methyl-D-aspartate receptors. J. Neurophysiol. 1998, 79:555-566.
60. Williams K. Separating dual effects of zinc at recombinant N-methyl-D-aspartate receptors. Neurosci. Lett. 1996, 215:9-12.
61. Zerangue N., Malan M.J., Fried S.R., Dazin P.F., Jan Y.N., Jan L.Y., Schwappach B. Analysis of endoplasmic reticulum trafficking signals by combinatorial screening in mammalian cells. Proc. Natl. Acad. Sci. USA 2001, 98:2431-2436.